Venture capital fund · 1 deal
Investment firm for early-stage healthcare companies
Sydney, NSW
Every published round KP Rx took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Navi Medical Technologies | Unnamed stage | 4 Aug 2026 | $6.8m | Lead | Startup Daily (Tue 4 Aug 2026), bushletter.com, medicalbuyer.co.in, SmartCompany, finsmes.com, raising.fi, vir.com.vn, PR Newswire (Wed 29 Jul 2026), meditechtoday.com, navitechnologies.com, Startup Daily (Tue 28 Jul 2026), PR Newswire (Tue 28 Jul 2026), finance.yahoo.com |
Companies KP Rx has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Navi Medical Technologies | 4 Aug 2026 | 1 | 1 |
Companies KP Rx's own portfolio page lists that no published round yet places it in. The page is the source; the round is being looked for.
| Company | Site |
|---|---|
| CurveBeam AI Ltd | curvebeamai.com ↗ |
| Inventia Life Science Pty Ltd | inventialifescience.com ↗ |
| Kitea Health Ltd | kiteahealth.com ↗ |
| Navi medical Technologies Pty Ltd | navitechnologies.com ↗ |
| Privacy Policy | cdn.prod.website-files.com ↗ |
| Skin2Neuron Pty Ltd | s2n.bio ↗ |
| Syntara Ltd | syntaratx.com.au ↗ |
Fund closes reported for KP Rx, as distinct from the investments it has made.
Companies KP Rx has backed that another company then bought. An exit for the holding, not a deal KP Rx did.
Stories naming KP Rx. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of eight Australian and New Zealand startups whose late-July funding totals $102 million across space capsules, medical devices, livestock breath analysis, sports analytics and AI crop forecasting.
Melbourne and Boston medical device firm Navi Medical Technologies has closed a 6.8 million dollar round led by KP Rx to commercialise its neonatal catheter technology in the United States.
Also Startup Daily·navitechnologies.com·meditechtoday.com·PR Newswire·vir.com.vn·SmartCompany·raising.fi·finsmes.com·finance.yahoo.com·Startup Daily·bushletter.com·medicalbuyer.co.in
Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.
Also Wholesale Investor
An executive interview with KP Rx founder Hashan De Silva on building a specialist healthcare venture firm investing in biotech and medical devices across Australia and New Zealand.
SYNthesis BioVentures' third investor letter reports a roughly A$7.5m first close for Alzheimer's biotech S2N, lists co-investors, and profiles managing director Amir's career across OneVentures, Ceres Capital and other life-sciences roles.